Here we attempt to bring together all the information, resources and updates being provided by all the African networks and pan-African organisations who work in health research.
The aim is to make it as easy as possible to find the right information, support and guidance, by connecting all the African initiatives together and making all the sources of reliable information and tools both accessible and discoverable.
Interactive Map of Cases
The ANTICOV clinical trial, conducted in 13 African countries, has started the recruitment of participants to test a new drug combination, nitazoxanide + ciclesonide, to treat people with mild-to-moderate COVID-19 before their cases become severe. The combination has two different mechanisms of action: one potentially active during the first, viral replication stage of SARS-COV-2 infection, and one that decreases the likelihood of an inflammatory stage that can start a few days later.
'In many African countries our worst fears are being realized, as already-strained intensive care units are beginning to fill up with COVID-19 patients. Yet the number of vaccine doses that are reaching the African continent is too limited. We need urgently to identify affordable and easy-to-administer treatments that can prevent the evolution to a severe form of the disease and slow the rate of infection.'
- Dr John Nkengasong, Director, Africa CDC
Key Regional Research Organisations
The following is a list of contacts within African organisations, including the WHO Africa, CDC Africa and EDCTP Centres of Excellence who are preparing to deal with this response. You can find more information also via the partner links listed in the right hand navigation.
Africa-CDC | African Society for Laboratory Medicine | WANETAM NoE | CANTAM NoE | EACCR NoE | TESA NoE | ALERRT | PANDORA
WHO AFRO | The EDCTP NoE | AAS | AVAREF
Africa Resources - per Country
Click your country to see links to government resources and advice on COVID-19.
If you have anything to add or suggestions on what would be useful please get in touch: firstname.lastname@example.org